Improved scientific advice for medicines for public health threats including antimicrobial resistance

EMA’s Emergency Task Force (ETF) is improving its approach to scientific advice for the most promising medicines and vaccines under development for public health threats.Under…, “With this new approach, developers will receive clear input on the design of clinical trials to allow generation of adequate evidence, and how these trials should be…, The approach will be crucial to enhance the rapid development and approval of medicines ahead of and during public health emergencies. The overall goal is to ensure alignment…